Injectable drug delivery system is infusion method, which administers drug into body by piercing the skin with the help of syringe attached to the needle. Most popular route it follows includes intravenous (IV), subcutaneous (SC) or Intramuscular (IM) and exhibit cent percent bioavailability. It is promising alternative for drugs, which are poorly absorbed or ineffective, when administered orally. Injectable drug delivery market includes drug delivery devices and drug formulations that are expected to grow with a promising CAGR during the forecast period. Profound analysis of injectable drug delivery provides various aspects of market such as market trends, product analysis, market drivers, restrains and opportunities. Competitive landscape section focuses on key leaders within injectable drug delivery market and their major strategies to capture the market. In-depth segmental analysis helps to understand the market dynamics and also would be benefit professionals in the decision-making process.
Injectable drug delivery systems are well known and highly accepted due to their faster onset of action with high efficacy. Injectable drug delivery market is primarily driven by rising incidences of chronic diseases such as diabetes and cancer. Management of product life cycle and advanced technologies has also fueled the growth of this market. Increasing popularity of biologics drug delivery through injectable route also supports the growth of this market. Maintenance of high sterile condition is essential to make the formulation contamination free. Hence, this market is characterized by strict regulatory guidelines to ensure the safety and quality of the formulations. Other restraining factors include infections arising due to contaminated needles, product recalls and high incidences of needle stick injuries. Development of efficacious biosimilars and emerging markets such as Brazil, India and China, are the significant growth opportunities.
Global Injectable Drug Delivery Market by Formulation Technologies
The global injectable drug delivery market is segmented into two major formulation technologies: conventional and novel drug delivery systems. Formulation technologies are the largest segments in the overall injectable drug delivery systems. The growth of this segment is attributed to the development of novel injectable systems such as Liposomes and Nanoparticles.
Global Injectable Drug Delivery Market by Device Technologies
Based on device technologies, the global injectable drug delivery market is broadly segmented into Conventional devices, Self-injecting devices and others. Conventional injectable devices form the largest segment in device technologies market. Self-injecting devices are the fastest growing segment in injectable devices market as it helps to solve the problem of patients not completing the dose cycle. This technology is cost effective as it decreases the number of hospital visits.
Global Injectable Drug Delivery Market by Application
Based on its applications, the global injectable drug delivery market is classified into different categories such as Hormonal Disorders, Auto-Immune Diseases, Oncology, Orphan/Rare Diseases and Others. Hormonal disorders dominate the application segment of injectable drug delivery devices market.
Global Injectable Drug Delivery Market by Geography
Geographically, global injectable drug delivery market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global injectable drug delivery market due to growing healthcare expenditures and technological advances. Asia-Pacific is the emerging market for global injectable drug delivery systems due to the potential the region has for expansion and growth. India, Brazil and China are the promising locations due to growing incidences of chronic diseases and growing healthcare infrastructure.
The key players within global injectable drug delivery market include Ypsomed Holding AG, Baxter International, Inc., Becton Dickinson & Co., Terumo Corporation, Antares Pharma, Inc., and Schott AG. The global injectable drug delivery market is highly competitive and diversified with big firms, mid-level firms and new firms. High cost of manufacturing and highly competitive environment forces market players to concentrate on merger and acquisition to attain sustainability in marketplace.
High Level Analysis
The comprehensive analysis of global injectable drug delivery market provides the overview of the market and the key concerns that hinder the market. The market segmentation concentrates on product distribution trends for each segment that would be benefit strategist. Market dynamics covers market drivers, restraints and opportunities, which would help to understand the market behavior. Porter’s five forces analysis would be helpful in determining the market profitability. Global injectable drug delivery market shows the presence of numerous manufacturers and buyers along with high cost of manufacturing. Moreover, there is a surge in self-injecting devices due to its advantages over other devices. All these factors add to the supplier’s forces and enhance their bargaining power. Global injectable drug delivery market is technology driven; therefore, there is a potential threat of technology obsolescence. Emerging technologies leads to development of alternative products leading to potential threat of substitute products. Industrial rivalry is intense due to growing competition to achieve sustainability.
This report offers the following benefits in particular:
The global injectable drug delivery market is segmented into four major categories: formulation, Device, Application and geography.
MARKET BY FORMULATION TECHNOLOGIES
MARKET BY DEVICE TECHNOLOGIES
MARKET BY THERAPEUTIC APPLICATION
MARKET BY GEOGRAPHY